ADVANCES IN ANTI-EMETIC THERAPY

[1] AAPRO MS, 1983, ASCO, V2, P93

[2] ANTI-EMETIC EFFICACY AND TOXICITY OF NABILONE, A SYNTHETIC CANNABINOID, IN LUNG-CANCER CHEMOTHERAPY [J]. BRITISH JOURNAL OF CANCER, 1983, 48 (05) : 657 - 663

[3] ALLAN S, 1984, ASCO, V3, P89

[4] ARNOLD DJ, 1980, P AM ASSOC CANC RES, V21, P344

[5] BAKER JJ, 1979, NEW ENGL J MED, V301, P728

[6] BRUERA ED, 1983, CANCER TREAT REP, V67, P381

[7] CHAN HSL, 1984, ASCO, V3, P108

[8] DELTA-9-TETRAHYDROCANNABINOL AS AN ANTI-EMETIC IN CANCER-PATIENTS RECEIVING HIGH-DOSE METHOTREXATE - PROSPECTIVE, RANDOMIZED EVALUATION [J]. ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) : 819 - 824

[9] CHANG AE, 1981, CANCER, V47, P1746

[10] ON THE RECEIVING END PATIENT PERCEPTION OF THE SIDE-EFFECTS OF CANCER-CHEMOTHERAPY [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (02): : 203 - 208

[1] AAPRO MS, 1983, ASCO, V2, P93

[2] ANTI-EMETIC EFFICACY AND TOXICITY OF NABILONE, A SYNTHETIC CANNABINOID, IN LUNG-CANCER CHEMOTHERAPY [J]. BRITISH JOURNAL OF CANCER, 1983, 48 (05) : 657 - 663

[3] ALLAN S, 1984, ASCO, V3, P89

[4] ARNOLD DJ, 1980, P AM ASSOC CANC RES, V21, P344

[5] BAKER JJ, 1979, NEW ENGL J MED, V301, P728

[6] BRUERA ED, 1983, CANCER TREAT REP, V67, P381

[7] CHAN HSL, 1984, ASCO, V3, P108

[8] DELTA-9-TETRAHYDROCANNABINOL AS AN ANTI-EMETIC IN CANCER-PATIENTS RECEIVING HIGH-DOSE METHOTREXATE - PROSPECTIVE, RANDOMIZED EVALUATION [J]. ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) : 819 - 824

[9] CHANG AE, 1981, CANCER, V47, P1746

[10] ON THE RECEIVING END PATIENT PERCEPTION OF THE SIDE-EFFECTS OF CANCER-CHEMOTHERAPY [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (02): : 203 - 208